Alnylam Pharmaceuticals
ALNY
#591
Rank
โ‚น2.962 T
Marketcap
โ‚น22,968
Share price
-0.29%
Change (1 day)
62.13%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚น354.78 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are โ‚น354.78 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚น318.83 B8.65%
2022-12-31โ‚น293.46 B8.22%
2021-12-31โ‚น271.17 B8.83%
2020-12-31โ‚น249.17 B45.89%
2019-12-31โ‚น170.79 B55.11%
2018-12-31โ‚น110.11 B-13.54%
2017-12-31โ‚น127.36 B48.42%
2016-12-31โ‚น85.81 B-6.87%
2015-12-31โ‚น92.14 B34.66%
2014-12-31โ‚น68.42 B163.36%
2013-12-31โ‚น25.98 B65.03%
2012-12-31โ‚น15.74 B5.56%
2011-12-31โ‚น14.91 B-15.37%
2010-12-31โ‚น17.62 B-21.1%
2009-12-31โ‚น22.33 B-16.22%
2008-12-31โ‚น26.66 B37.58%
2007-12-31โ‚น19.37 B82.31%
2006-12-31โ‚น10.62 B140.19%
2005-12-31โ‚น4.42 B54.58%
2004-12-31โ‚น2.86 B78.72%
2003-12-31โ‚น1.60 B107.34%
2002-12-31โ‚น0.77 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚น74.56 B-78.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.159 T 790.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น288.91 B-18.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น167.04 B-52.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.78 B-97.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.734 T 2,361.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น11.735 T 3,207.82%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น3.487 T 883.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel